Vicarious Surgical Inc. (RBOT): Nasdaq/NYSE listing notice — Vicarious Surgical receives NYSE delisting notice; trading suspended, moves to OTCID

Vicarious Surgical Inc.

NYSE notified Vicarious Surgical on Mar 3, 2026 of delisting for falling below $15M avg mkt cap over 30 trading days.
Trading suspended after market close Mar 3, 2026; company evaluating whether to appeal within 10 business days.
Common stock expected to commence quotation on OTCID tier on Mar 4, 2026 under symbol RBOT.
Delisting may reduce liquidity, market price, and ability to raise equity financing.
OTC markets significantly more limited than NYSE; company provides no assurance of continued trading.

item 3.01 item 7.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

Vicarious Surgical Inc. received a nyse delisting notice notice regarding market value (rules 802.01B).

Exchange: nyse
Notice: delisting notice
Deficiency: market value
Rules: 802.01B

Exact text from the filing

March 3, 2026, the New York Stock Exchange (the “NYSE”) notified Vicarious Surgical Inc. (the “Company”) that the NYSE had determined to (A) immediately suspend trading in the Company’s common stock, par value $0.0001 per share (the “Common Stock”), due to a determination that the Company had fallen below the NYSE’s continued listing standard requiring listed companies to maintain an average global market capitalization over a consecutive 30 trading day period of at least $15,000,000 pursuant to Section 802.01B of the NYSE Listed Company Manual, and (B) commence proceedings to delist the Commo

View on SEC.gov

Browse all listing & compliance notices →

Vicarious Surgical Inc. filing history →

Source: SEC EDGAR

accession 0001213900-26-023404

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.